In Pursuit of Pharma/BioTech Opportunity

Date: Tuesday, June 02 · 8:30 PM - 9:45 PM EDT
Location: Online

Ardelyx (ARDX) has generated a 107% return for the Round Table portfolio.

Other companies like Regeneron Pharma (REGN), Gilead Sciences (GILD) and BioSpecifics Technologies (BSTC) have proved particularly rewarding and have significantly bolstered the Round Table results.

Other exploits over the years have included a very rewarding tour with Walgreen as we watched them kiss and make up with Express Scripts. Back in 2012, Hugh delivered a couple of educational sessions on profiting from the FDA pipeline that still rank as some of the most favored (by an order of magnitude) sessions stored on our YouTube channel.

Hugh’s back.

Join us for this entertaining and educational webcast.